Symptom-related patient-provider communication among women with breast cancer receiving chemotherapy.

Autor: Whisenant MS; Department of Research, Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, TX, United States; Department of Nursing, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: meagan.whisenant@uth.tmc.edu., Coombs LA; University of North Carolina Chapel Hill School of Nursing, Lineberger Comprehensive Cancer Center, Chapel Hill, NC, United States., Wilson C; University of Utah College of Nursing, Salt Lake City, UT, United States., Mooney K; University of Utah College of Nursing, Salt Lake City, UT, United States; Huntsman Cancer Institute, Salt Lake City, UT, United States.
Jazyk: angličtina
Zdroj: European journal of oncology nursing : the official journal of European Oncology Nursing Society [Eur J Oncol Nurs] 2021 Dec; Vol. 55, pp. 102064. Date of Electronic Publication: 2021 Nov 14.
DOI: 10.1016/j.ejon.2021.102064
Abstrakt: Purpose: The purpose of this study was to determine the extent to which women being treated for breast cancer discussed their symptoms during the week prior to a clinic visit.
Method: Women reported the severity of 11 symptoms (0-10 scale) daily using an automated patient-reported outcomes system. Clinic visits were audio recorded, and symptom discussions were coded. Moderate to severe symptoms reported in the week prior to the visit were compared to the symptoms discussed at the visit.
Results: Twenty-six clinic visits of 10 women (mean age, 51.6 years; half had advanced disease) were recorded. In the week prior to their visits, participants provided 183 reports of moderate to severe symptoms. Reported symptoms were discussed at 49.5% of visits, with 36% of discussions initiated by patients. These discussions were more likely to include assessment and normalizing and were less focused on intensifying symptom management. Symptom discussions were more likely with younger women and the time spent discussing symptoms decreased over subsequent visits for all women.
Conclusions: Women who are symptomatic during treatment are not systematically queried about their symptoms, nor are women effectively reporting their symptoms. Attention should be directed at eliciting symptoms from older women; symptoms should be discussed throughout the duration of chemotherapy.
(Copyright © 2021 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: